Posted by Michael Wonder on 31 Oct 2016
Schedule of Pharmaceutical Benefits - 1 November 2016 update
1 November 2016 - The 1 November 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new and revised listings.
The new/revised listings are:
- Armodafinil (Nuvigil) - new listing
- Auranofin (Ridaura) - new formulation
- Dexamethasone (Ozurdex) - new indication
- LIpegfilgrastim (Lonquex) - new listing
- Ribavirin (Ibavyr) - new strength
- Ruxolitinib phosphate (Jakavi) - new strength
